Simes J - Search Results

1

Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer.

Lee CK, Davies L, Gebski VJ, Lord SJ, Di Leo A, Johnston S, Geyer C Jr, Cameron D, Press MF, Ellis C, Loi S, Marschner I, Simes J, de Souza P. Lee CK, et al. Among authors: simes j. J Clin Oncol. 2016 Mar 20;34(9):936-44. doi: 10.1200/JCO.2015.62.4767. Epub 2016 Jan 25. J Clin Oncol. 2016. PMID: 26811533

2

Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.

Segelov E, Thavaneswaran S, Waring PM, Desai J, Robledo KP, Gebski VJ, Elez E, Nott LM, Karapetis CS, Lunke S, Chantrill LA, Pavlakis N, Khasraw M, Underhill C, Ciardiello F, Jefford M, Wasan H, Haydon A, Price TJ, van Hazel G, Wilson K, Simes J, Shapiro JD. Segelov E, et al. Among authors: simes j. J Clin Oncol. 2016 Jul 1;34(19):2258-64. doi: 10.1200/JCO.2015.65.6843. Epub 2016 Apr 25. J Clin Oncol. 2016. PMID: 27114605 Clinical Trial.

3

Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysis.

Kok PS, Cho D, Yoon WH, Ritchie G, Marschner I, Lord S, Friedlander M, Simes J, Lee CK. Kok PS, et al. Among authors: simes j. JAMA Netw Open. 2020 Sep 1;3(9):e2011809. doi: 10.1001/jamanetworkopen.2020.11809. JAMA Netw Open. 2020. PMID: 32897371 Free PMC article.

4

Clinical Equipoise for Trials of Novel Biologic Therapies, Therapeutic Success Rates, and Predictors of Success: A Meta-Analysis.

Cho D, Roncolato FT, Man J, Simes J, Lord SJ, Links MJ, Lee CK. Cho D, et al. Among authors: simes j. JCO Precis Oncol. 2017 Nov;1:1-12. doi: 10.1200/PO.17.00062. JCO Precis Oncol. 2017. PMID: 35172509

5

Extrapolating evidence for molecularly targeted therapies from common to rare cancers: a scoping review of methodological guidance.

Cho D, Cheyne S, Lord SJ, Simes J, Lee CK. Cho D, et al. Among authors: simes j. BMJ Open. 2022 Jul 12;12(7):e058350. doi: 10.1136/bmjopen-2021-058350. BMJ Open. 2022. PMID: 35820758 Free PMC article. Review.

6

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J; Australasian Gastro-Intestinal Trials Group. Gebski V, et al. Among authors: simes j. Lancet Oncol. 2007 Mar;8(3):226-34. doi: 10.1016/S1470-2045(07)70039-6. Lancet Oncol. 2007. PMID: 17329193

7

Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.

Gebski V, Lagleva M, Keech A, Simes J, Langlands AO. Gebski V, et al. Among authors: simes j. J Natl Cancer Inst. 2006 Jan 4;98(1):26-38. doi: 10.1093/jnci/djj002. J Natl Cancer Inst. 2006. PMID: 16391369

8

Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis.

Verry H, Lord SJ, Martin A, Gill G, Lee CK, Howard K, Wetzig N, Simes J. Verry H, et al. Among authors: simes j. Br J Cancer. 2012 Mar 13;106(6):1045-52. doi: 10.1038/bjc.2012.62. Br J Cancer. 2012. PMID: 22415293 Free PMC article.

9

AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.

Oar A, Lee M, Le H, Wilson K, Aiken C, Chantrill L, Simes J, Nguyen N, Barbour A, Samra J, Sjoquist KM, Moore A, Espinoza D, Gebski V, Yip S, Chu J, Kneebone A, Goldstein D. Oar A, et al. Among authors: simes j. BMC Cancer. 2021 Aug 19;21(1):936. doi: 10.1186/s12885-021-08666-y. BMC Cancer. 2021. PMID: 34412605 Free PMC article.

10

Next-generation sequencing, should I use anti-HER2 therapy for HER2-amplified tumors off-label? Illustrating an extrapolation framework.

Cho D, Lord SJ, Simes J, Cooper W, Friedlander M, Bae S, Lee CK. Cho D, et al. Among authors: simes j. Ther Adv Med Oncol. 2022 Jul 29;14:17588359221112822. doi: 10.1177/17588359221112822. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35923921 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page